SCHEMBL8007728

SCHEMBL8007728

CCOc1cc(C(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)ccc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.54
ALDH1A1 P00352 1/20 0.54
MAPK1 P28482 1/20 0.53
STAT3 P40763 1/20 0.53
LMNA P02545 1/20 0.51
POLB P06746 1/20 0.51
MAPT P10636 1/20 0.51
PKM P14618 1/20 0.50
MMP2 P08253 2/20 0.49
NPC1 O15118 1/20 0.49
USP2 O75604 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TSHR P16473 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
PDE4A P27815 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL942391 0.84 STAT3 (0.58) KDM4EALDH1A1STAT3LMNAPOLB
SCHEMBL4826029 0.82 TSHR (0.72) ALDH1A1MAPK1LMNANPC1USP2
SCHEMBL939334 0.81 STAT3 (0.50) KDM4EALDH1A1STAT3LMNAPOLB
SCHEMBL5076592 0.80 TSHR (0.76) ALDH1A1MAPK1LMNANPC1USP2
SCHEMBL8001580 0.80 PDE4D (0.44) KDM4EALDH1A1MAPK1STAT3LMNA
SCHEMBL940166 0.78 MMP2 (0.60) ALDH1A1MAPK1STAT3LMNAMAPT
SCHEMBL11115008 0.78 STAT3 (0.55) KDM4EALDH1A1STAT3LMNAPOLB
SCHEMBL4826406 0.78 PDE4A (0.76) ALDH1A1MAPK1LMNANPC1USP2
SCHEMBL11116710 0.76 STAT3 (0.53) KDM4EALDH1A1STAT3LMNAPOLB
SCHEMBL941153 0.76 MMP2 (0.54) MMP2TSHRTP53CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009118292-A1 ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS NOVARTIS AG (CH) 2009-10-01 WO disclosed